News – Page 1162 – Endpoints News

Merck bags a PhIII CMV victory in the wake of a flop at rival Chimerix

9 years ago

Gene editing loses its sizzle. CRISPR Therapeutics IPO debuts beneath the range

9 years ago

Kite CEO Arie Belldegrun preps for a looming date with the FDA as he tackles first-mover advantage in CAR-T

9 years ago

New Vancouver-based fund has $100M to invest in biotech; FDA hands out $23M in rare disease R&D grants

9 years ago

The Medicines Company touts fresh evidence that their PCSK9si can durably bat down LDL

9 years ago

Nancy Stagliano bags another $45M for True North’s rare disease R&D

9 years ago

Armed antibody player ADC lands a $105M mega-round to back pipeline construction

9 years ago

Pfizer launching first US mAb biosimilar with Remicade knockoff, but you can forget about any fire sale

9 years ago

Vertex snares $75M windfall in revised CFF deal; Ex-Celgene R&D prez Daniel starts advisory group

9 years ago

Sofinnova bags $650M for a dedicated biotech fund

9 years ago

PTC shares plunge anew after FDA slaps down Duchenne drug for a second time

9 years ago

Safety threat forces FDA to put a hold on Regeneron, Teva’s big NGF pain drug fasinumab

9 years ago

Clinton campaign staff: "We have started the war with pharma!!"

9 years ago

Now with actual data in hand, Celgene touts an early response for Crohn’s drug mongersen

9 years ago

Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser

9 years ago

Flex Pharma's cramp study fails, shares plunge; FDA makes Egalet wait on pain drug

9 years ago

Sarepta lands a valuable priority review voucher on Exondys 51 OK

9 years ago

Post-merger, gene therapy player Adverum makes Amber Salzman CEO, delays a clinical trial start

9 years ago

Boehringer-Ingelheim has some explaining to do; It's time biotech came to grips with compassion

9 years ago

Biotechs grabbed $1.83B in VC cash in Q3. Still fast but a little less furious

9 years ago

FDA's controversial OK for eteplirsen spurs second thoughts for a rejected rival at BioMarin

9 years ago

NeuroVive shares crater on PhII flop; F-Prime contributes $7.5M in startup cash for Akriveia

9 years ago

The compassionate use poll: A lopsided vote favors posting policies, with plenty of fretting

9 years ago

Tesaro v Myriad: Niraparib partners squared off in court as Tesaro tried to quash a contrary press release

9 years ago

First page Previous page 1159 1160 116111621163 1164 1165 Next page Last page